Amwell (NYSE: AMWL) reported Q2 EPS of ($0.59), $0.30 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $52.05 million versus the consensus estimate of $50.1 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.